Magrolimab-induced transient decrease of red blood cells (RBCs) and hemoglobin corroborates clinical findings

This article is currently being updated. View its version on PubMed.

https://www.genoway.com/product/catalog/cd47-sirpa#Valisation

Research summary

Key outcome of the study

Model

TARGET:

Keywords

Technical specifications

Related products

Catalogue product

No items found.

Customized product

No items found.